Lyell Immunopharma Inc (LYEL)

Stock price, financials, and technical signals for Lyell Immunopharma Inc (LYEL).

$0.47

0

(0%)

As of 04/04/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

LYEL Performance Snapshot


1-Week Chg

-14.05%

1-Month Chg

-33.95%

3-Month Chg

-33.38%

6-Month Chg

-61.89%

1-Year Chg

-77.75%

Year-To-Date Chg

-27.91%

Beta 1-Year

1.73

Beta 5-Year

-0.13

Volatility (10-Day)

7.79%

LYEL Technicals



Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-04-04

$0.47

$0 (0%)

$0.46

$0.50

$0.44

$0.47

723.72K ($336.53K)

2025-04-03

$0.47

-$0.04 (-8.28%)

$0.49

$0.50

$0.46

$0.48

888.35K ($413.08K)

2025-04-02

$0.51

$0.02 (4.75%)

$0.48

$0.51

$0.48

$0.50

600.99K ($304.70K)

2025-04-01

$0.48

-$0.05 (-10.04%)

$0.52

$0.55

$0.48

$0.50

662.82K ($320.81K)

2025-03-31

$0.54

-$0.00 (-0.55%)

$0.56

$0.57

$0.52

$0.54

869.76K ($467.93K)

2025-03-28

$0.54

-$0.05 (-8.92%)

$0.59

$0.62

$0.54

$0.57

615.13K ($332.79K)

2025-03-27

$0.59

$0.04 (6.45%)

$0.57

$0.63

$0.57

$0.60

793.53K ($471.36K)

2025-03-26

$0.56

$0.03 (6.29%)

$0.55

$0.60

$0.54

$0.56

703.38K ($392.48K)

2025-03-25

$0.53

-$0.03 (-6.08%)

$0.56

$0.56

$0.53

$0.54

546.22K ($286.76K)

2025-03-24

$0.56

-$0.02 (-3.45%)

$0.58

$0.59

$0.55

$0.57

482.86K ($269.92K)

LYEL Financials


Balance Sheet

(USD)

2024 Q4

Y/Y CHANGE


  • Cash and equivalents

    $107.29M

    -26.48%

  • Total assets

    $490.86M

    -34.55%

  • Total liabilities

    $108.03M

    13.63%

  • Total investments

    $296.94M

    -33.88%

  • Shareholders' equity

    $382.82M

    -41.55%

  • Book value per share

    $1.37

    -47.24%


Income Statement

(USD)

2024 Q4

Y/Y CHANGE


  • Revenue

    $11.00K

    -15.38%

  • Net income

    -$191.94M

    -262.62%

  • Operating expense

    $201.16M

    237.96%

  • Gross profit

    $11.00K

    -15.38%

  • EBITDA

    -$186.91M

    -290.43%

  • Earnings per share

    -$0.72

    -260.00%


Cash Flow

(USD)

2024 Q4

Y/Y CHANGE


  • Net change in cash

    $6.70M

    104.77%

  • Cash from operations

    -$47.24M

    -16.26%

  • Cash from investing

    $53.51M

    153.14%

  • Cash from financing

    $437.00K

    -42.42%

  • Free cash flow

    -$47.29M

    -16.30%

  • Free cash flow per share

    -$0.17

    -4.97%


Metrics

(USD)

2024 Q4

Y/Y CHANGE


  • Market capitalization

    $178.70M

    -63.43%

  • Enterprise value

    $129.56M

    -50.31%

  • Shares outstanding

    279.22M

    10.86%

  • Profit margin

    -1744863.60%

    -328.55%

  • Gross margin

    100.00%

    0%

  • EBITDA margin

    -1699172.70%

    -361.41%


Dividends

(USD)

2024 Q4

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    7.06

    -56.08%


Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.